Induction of protective immunity by DNA vaccination with Toxoplasma gondii HSP70, HSP30 and SAG1 genes

Vaccine

Volumn 21, Issue 21-22, 2003, Pages 2852-2861

  Mohamed, Rabie M ^a   Aosai, Fumie ^a   Chen, Mei ^a   Mun, Hye Seong ^a   Norose, Kazumi ^a   Belal, Usama S ^a   Piao, Lian Xun ^a   Yano, Akihiko ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Gene gun vaccination; T.g.HSP70; Toxoplasma gondii

Indexed keywords

DNA VACCINE; HEAT SHOCK PROTEIN 30; HEAT SHOCK PROTEIN 70; PLASMID DNA; PROTEIN; PROTEIN SAG1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; GENE GUN; GENE INDUCTION; IMMUNITY; MOUSE; NONHUMAN; PARASITE SURVIVAL; PRIORITY JOURNAL; TOXOPLASMA GONDII; TOXOPLASMOSIS; VACCINATION;

EID: 0037836948     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00157-9     Document Type: Article

References (51)

1. Denkers E.Y., Gazzinelli R.T. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev. 11(4):1998;569-588.
2. Haumont M., Delhaye L., Garcia L.et al. Protective immunity against congenital toxoplasmosis with recombinant SAG1 protein in a guinea pig model. Infect. Immun. 68(9):2000;4948-4953.
3. Stevenson F.K., Rosenberg W. DNA vaccination: a potential weapon against infection and cancer. Vox Sanguinis. 80:2001;12-18.
4. Mendez S., Gurunathan S., Kamhawai S.et al. The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge. J. Immunol. 166:2001;5122-5128.
5. Leitner W.W., Seguin M.C., Ballou W.R.et al. Immune response induced by intramuscular or gene gun injection of protective deoxyribonucleic protein from Plasmodium berghei malaria parasites. J. Immunol. 159:1997;6112-6119.
6. Belperron A.A., Feltquate D., Fox B.A., Horii T., Bzik B.A. Immune responses induced by gene gun or intramuscular injection of DNA vaccines that express immunogenic regions of the serine repeat antigen from Plasmodium falciparum. Infect. Immun. 67(10):1999;5163-5169.
7. Planells L., Thomas C.M., Alonso C., Lopez M. DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection. Infect. Immun. 69(10):2001;6558-6563.
8. Saito S., Aosai F., Rikihisa N.et al. Establishment of gene-vaccinated skin grafting against Toxoplasma gondii infection in mice. Vaccine. 19:2001;2172-2180.
9. Desolme B., Mevelece M.N., Buzoni-Gatel D., Bout D. Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene. Vaccine. 18:2000;2512-2521.
10. Vercammen M., Scorza T., Huygen K.et al. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7 and ROP2 induces partially protective immunity against lethal challenge in mice. Infect. Immun. 68(1):2000;38-45.
11. Binder R., Harris M., Menoret A., Srivastava P. Saturation, competition and specifity in interaction of heat shock proteins (hsp) gp96, hsp90 and hsp70 with CD11b+ cells. J. Immunol. 165:2000;2582-2587.
12. Singh-Jasuja H., Toes R., Spee P.et al. Cross presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis. J. Exp. Med. 191:2000;1965-1974.
13. Suto R., Srivastava P.K. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science. 269:1995;1585-1588.
14. Castellino F., Boucher P.E., Eichelberg K.et al. Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways. J. Exp. Med. 191:2000;1957-1964.
15. kB pathway. Int. Immunol. 12:2000;1539-1546.
16. Binder R., Anderson K., Basu S., Srivastava P. Cutting edge: heat shock protein gp96 induces maturation and migration of CD11c(+) cells in vivo. J. Immunol. 165:2000;6029.
17. Srivastava P. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune response. Ann. Rev. Immunol. 20:2002;395-425.
18. Srivastava P.K., Amato R.J. Heat shock proteins: the 'Swiss army knife' vaccine against cancers and infectious agents. Vaccine. 19:2001;2590-2597.
19. Gupta R., Golding G.B. Evolution of hsp70 gene and its implications regarding relationships between archaebacteria. J. Mol. Evol. 37:1993;573-582.
20. Kuppner M.C., Gastpar R., Gelwer S.et al. The role of heat shock protein (hsp70) in dendretic cell maturation: Hsp70 induces the maturation of immature dendretic cells but reduces DC differentiation from monocyte precursors. Eur. J. Immunol. 31:2001;1602-1609.
21. Fernandez N.C., Lozier A., Flament C.et al. Dendretic cells directly trigger NK cell functions: cross-take relevant in innate anti-tumor immune responses in vivo. Nat. Med. 5:1999;405-411.
22. + CTL. Microbiol. Immunol. 41(7):1997;553-561.
23. Yano A, Mun HS, Yang TH, et al. Roles of IFN-γ in effector mechanisms and pathogenecity of HSPs in mice and humans infected with Toxoplasma gondii. In: Tada I, Kojima S, Tsuji M, editors. Proceedings of the ICOPA 9th International Congress of Parasitology. International Proceedings Division, Monduzzi Editore, Italy, 1998. p. 457-66.
24. Mun H.S., Aosai F., Yano A. Role of Toxoplasma gondii HSP70 and Toxoplasma gondii HSP30/bag1 in antibody formation and prophylactic immunity in mice experimentally infected with Toxoplasma gondii. Microbiol. Immunol. 43(5):1999;471-479.
25. Mun H.S., Aosai F., Norose K.et al. Toxoplasma gondii Hsp70 as a danger signal in Toxoplasma gondii infected mice. Cell Stress Chaperones. 5(4):2000;328-335.
26. Chen M., Aosai F., Mun H.S., Norose K., Hata H., Yano A. Anti-HSP70 auto-antibody formation by B-1 cells in Toxoplasma gondii-infected mice. Infect. Immun. 68(9):2000;4893-4899.
27. Aosai F., Chen M., Kang H.K.et al. Toxoplasma gondii-derived heat shock protein HSP70 functions as a B cell mitogen. Cell Stress Chaperones. 7(4):2002;357-364.
28. Aosai F., Mun H.S., Norose K.et al. Protective immunity induced by vaccination with SAG1-transfected cells against Toxoplasma gondii-infected mice. Microbiol. Immunol. 43(1):1999;87-91.
29. Leyva R., Herion P., Saavedra R. Genetic immunization with plasmid coding for ROP2 protein of Toxoplasma gondii. Parasitol. Res. 87:2001;70-79.
30. -/- mice. J. Immunol. 159:1997;1418-1428.
31. + cytotoxic cells. J. Parasitol. 75:1989;411-416.
32. Luo W., Aosai F., Ueda M.et al. Kinetics in parasite abundance in susceptible and resistant mice infected with an avirulent strain of Toxoplasma gondii by using quantitative competitive PCR. J. Parasitol. 83:1997;1070-1074.
33. Yano A., Mun H.S., Chen M.et al. Roles of IFN-γ on stage conversion of an obligate intracellular protozoan parasite, Toxoplasma gondii. Int. Rev. Immunol. 21:2002;1-18.
34. Todryk S., Melcher A.A., Dalgleish A.G., Vile R.G. Heat shock proteins refine the danger theory. Immunology. 99:2000;334-337.
35. Tighe H., Corr M., Roman M., Raz E. Gene vaccination: plasmid DNA is more than just a blueprint. Immunol. Today. 19(2):1998;89-97.
36. Grunathan S., Klinman D.M. DNA vaccines: immunostimulatory, application and optimization. Ann. Rev. Immunol. 18:2000;927-974.
37. Klinman D.M., Yi A.K., Beaucage S.L., Conver J., Kreig A.M. CPG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin-6, interleukin-12, and interferon gamma. Proc. Natl. Acad. Sci. U.S.A. 93:1996;2879-2883.
38. Sato Y., Roman M., Tighe H.et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science. 273:1996;352-354.
39. Suzuki Y., Orellan M.A., Schreiber R.D., Remington J.S. Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science. 240:1988;516-518.
40. Kobayashi M., Aosai F., Hata H.et al. Toxoplasma gondii: differences of invasion into tissue of digestive organs between susceptible and resistant strain and influence of IFN-γ in mice inoculated with the cyst perorally. J. Parasitol. 85(5):1999;973-975.
41. Liesenfeld O., Nguyen T.A., Pharke C., Suzuki Y. Importance of gender and sex hormones in regulation of susceptibility of the small intestine to peroral infection with Toxoplasma gondii tissue cysts. J. Parasitol. 87(6):2002;1491-1493.
42. Yoshida A., Nagata T., Uchijima M., Higashi T., Koide Y. Advantage of gene gun-mediated over intramuscular inoculation of plasmid DNA vaccine in reproducible induction of specific immune responses. Vaccine. 18:2000;1725-1729.
43. Bennett A.M., Phillpotts R.J., Perkins S.D., Jacobs S.C., Williamson E.D. Gene gun mediated vaccination is superior to manual delivery for immunization with DNA vaccines expressing protective antigens from Yersinia pestis or Venzuelan equine encephalitis virus. Vaccine. 18:2000;588-596.
44. + T cell immunogenicity and protective efficacy in the influenza and malaria models. Vaccine. 18:2000;623-632.
45. Todryk S., Melcher A.A., Hardwick N.et al. Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendretic cell precursors to enhance antigen uptake. J. Immunol. 163:1999;1398-1408.
46. Bohm W., Mertens T., Schirmbeck R., Reimann J. Routes of plasmid DNA vaccination that prime murine humoral and cellular immune responses. Vaccine. 16:1998;949-954.
47. Rhee E.G., Mendez S., Shah J.A.et al. Vaccination with heat-killed Leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4 and CD8 T-cell responses and protection against Leishmania major infection. J. Exp. Med. 195(12):2002;1565-1573.
48. Stobie L., Grunathan S., Prussin C.et al. The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge. Proc. Natl. Acad. Sci. U.S.A. 97(15):2000;8427-8432.
49. Letscher-Bru V., Villard O., Risse B., Zauke M., Klein J.P., Kien T.T. Protective effects of vaccination with a combination of recombinant surface antigen 1 and interleukin-12 against toxoplasmosis in mice. Infect. Immun. 66(9):1998;4503-4506.
50. Mishima M., Xuan X., Shioda A.et al. Modified protection against Toxoplasma gondii lethal infection and brain cyst formation by vaccination with SAG2 and SRS1. J. Vet. Med. Sci. 63(4):2001;433-438.
51. Angus C.W., Klivington-Evans D., Dubey J.P., Kovacs J.A. Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents. JID. 181:2000;317-324.